v3.26.3
Segment information (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
segment
Sep. 30, 2025
USD ($)
Segment Reporting [Abstract]        
Number of operating segments | segment     1  
Number of reportable segments | segment     1  
Operating expenses:        
Selling, general and administrative $ 21,916 $ 26,414 $ 40,885 $ 58,994
Total operating expenses 56,281 84,291 124,529 174,715
Loss from operations (56,281) (84,291) (124,529) (174,715)
Other (expense) income, net (840) 1,191 (2,358) 4,922
Net loss (57,121) (83,100) (126,887) (169,793)
Reportable Segment        
Operating expenses:        
Unallocated research and development expenses 16,039 34,420 46,006 71,969
Selling, general and administrative 21,916 26,414 40,885 58,994
Total operating expenses 56,281 84,291 124,529 174,715
Loss from operations (56,281) (84,291) (124,529) (174,715)
Other (expense) income, net (840) 1,191 (2,358) 4,922
Net loss (57,121) (83,100) (126,887) (169,793)
IGNYTE | Reportable Segment        
Operating expenses:        
RP1 program costs by study 903 2,562 1,578 6,014
ARTACUS | Reportable Segment        
Operating expenses:        
RP1 program costs by study 648 1,616 1,132 3,235
CERPASS | Reportable Segment        
Operating expenses:        
RP1 program costs by study 176 1,433 (94) 2,640
IGNYTE-3 | Reportable Segment        
Operating expenses:        
RP1 program costs by study 6,818 6,474 14,768 11,335
Other RP1 study costs | Reportable Segment        
Operating expenses:        
RP1 program costs by study 39 5,539 1,439 9,963
RP2 | Reportable Segment        
Operating expenses:        
RP1 program costs by study 9,439 5,253 18,266 9,128
RP3 | Reportable Segment        
Operating expenses:        
RP1 program costs by study $ 303 $ 580 $ 549 $ 1,437